The NHS, through the support of CK Group, has this week launched the world’s largest trial of the pioneering early-detection cancer test, which can identify 50 types of cancer before symptoms start – including many that are difficult to diagnose.
More than 100,000 people will take part in the trial by providing blood samples to be analysed through the ground-breaking Galleri test, which could one day be rolled out to become routinely available through the NHS. It will help thousands more people get successful treatment every year, and could be a game-changer in early cancer care.
The trial will operate through eight Cancer Alliances across England, covering a range of locations including Greater Manchester, South East London and the West Midlands. Mobile units provided by EMS Healthcare will be placed within each Cancer Alliance to give geographical reach of participants.
CK Group’s clinical division has provided a wealth of support to the incredible trial, recruiting for the 84 research nurses involved in performing the Galleri test and administering the study.
Recruitment Manager Russell Oakley has said about the project “It’s such a great privilege to be partnering with EMS Healthcare on the GRAIL Galleri trial, helping in the fight with cancer. As a specialist clinical recruiter I don’t always get to see the whole picture of a clinical trial, but the Galleri test will enable myself and the team here at CK Group to see how the study unfolds by supporting the dedicated team of nurses involved. Exciting times for us.”
If successful, the new test could play a major part in achieving the NHS’s ambition of catching three quarters of cancers at an early stage. This means that it really is the beginning of a revolution, and CK Group are proud to have had an involvement in its trial.
